Appointments: CRISPR, KSQ Therapeutics, Immunocore, Cellectis, Translate Bio and biOasis

09 Oct 2017

• By Lubna Ahmed

This week's roundup includes CEO appointments by CRISPR Therapeutics and KSQ Therapeutics, in addition to various other board and high-level appointments by Oncorus, Cellectis, BiOasis, Avillion and Revolution Medicines.

CRISPR Therapeutics AG has promoted Samarth Kulkarni to CEO – effective Dec. 1, 2017. Kulkarni joined the company as chief business officer and most recently he was president of CRISPR Therapeutics Inc.Co-founder and current CEO Rodger Novak will be stepping down and continuing as a member of CRISPR's board of directors and an officer of its Swiss parent company, CRISPR AG.

David Meeker has been appointed CEO of KSQ Therapeutics. Most recently he was head of Sanofi-Genzyme Corp.'s...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Executives On The Move: Five New CEOs Among This Week’s Changes

18 Jul 2025

Recent moves in the industry include changes at the top at Ascentage Pharma, Inventiva and Brenig Therapeutics, plus five companies get new CFOs.

Executives On The Move: New CEOs At Outlook Therapeutics And Peptomyc

10 Jul 2025

Recent moves in the industry include C-suite changes at Essential Pharma, plus Kyverna Therapeutics gets new chief financial officer from Alector.

Kris Joshi Named Norstella CEO, Prioritizes AI Innovation

09 Jul 2025

• By Aakash Babu

Joshi joins the parent company of Citeline, which houses flagship publications Scrip and Pink Sheet, to focus on AI, business harmonization and long-term growth.

Executives On The Move: New CEOs At Sun Pharma And TME Pharma

03 Jul 2025

Recent moves in the industry include C-suite changes at Abvance Therapeutics, plus Galapagos gets new chief financial officer from Horizon Therapeutics.